Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.

Satterwhite S, Knight KR, Miaskowski C, Chang JS, Ceasar R, Zamora K, Kushel M.

J Am Board Fam Med. 2019 May-Jun;32(3):375-382. doi: 10.3122/jabfm.2019.03.180306.

2.

Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use.

Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C.

Soc Sci Med. 2017 Aug;186:87-95. doi: 10.1016/j.socscimed.2017.05.043. Epub 2017 May 23.

3.

The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.

Hurstak EE, Kushel M, Chang J, Ceasar R, Zamora K, Miaskowski C, Knight K.

Subst Abus. 2017 Apr-Jun;38(2):213-221. doi: 10.1080/08897077.2017.1296524. Epub 2017 Apr 10.

4.

Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net.

Chang JS, Kushel M, Miaskowski C, Ceasar R, Zamora K, Hurstak E, Knight KR.

Subst Use Misuse. 2017 Jan 28;52(2):251-255. Epub 2016 Oct 18.

5.

Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings.

Ceasar R, Chang J, Zamora K, Hurstak E, Kushel M, Miaskowski C, Knight K.

Subst Abus. 2016;37(1):154-60. doi: 10.1080/08897077.2015.1132293.

6.

Statistical exploration of variation in quantitative two-dimensional gel electrophoresis data.

Gustafsson JS, Ceasar R, Glasbey CA, Blomberg A, Rudemo M.

Proteomics. 2004 Dec;4(12):3791-9.

PMID:
15378705

Supplemental Content

Loading ...
Support Center